These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3420678)

  • 1. Some observations on the Inb antigen and evidence that anti-Inb causes accelerated destruction of radiolabeled red cells.
    Ferguson DJ; Gaal HD
    Transfusion; 1988; 28(5):479-82. PubMed ID: 3420678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of anti-Yt(b). Report of a case using a 51chromium red cell survival study.
    Levy GJ; Selset G; McQuiston D; Nance SJ; Garratty G; Smith LE; Goldfinger D
    Transfusion; 1988; 28(3):265-7. PubMed ID: 3285526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-Jka, -C, and -E in a single patient, initially demonstrable only by the manual hexadimethrine bromide (Polybrene) test, with incompatibilities confirmed by 51Cr-labeled red cell studies.
    Maynard BA; Smith DS; Farrar RP; Kraetsch RE; Chaplin H
    Transfusion; 1988; 28(4):302-6. PubMed ID: 3133842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinically significant allo-anti-I in an I-negative patient with massive hemorrhage.
    Chaplin H; Hunter VL; Malecek AC; Kilzer P; Rosche ME
    Transfusion; 1986; 26(1):57-61. PubMed ID: 3946005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An example of anti-Yta demonstrating a change in its clinical significance.
    AuBuchon JP; Brightman A; Anderson HJ; Kim B
    Vox Sang; 1988; 55(3):171-5. PubMed ID: 3238951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel single-nucleotide change in GYP*A in a person who made an alloantibody to a new high-prevalence MNS antigen called ENEV.
    Velliquette RW; Hu Z; Lomas-Francis C; Hue-Roye K; Allen JL; Mirabella D; Reid ME
    Transfusion; 2010 Apr; 50(4):856-60. PubMed ID: 20003059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 51Chromium survival of Yt(a+) red cells as a determinant of the in vivo significance of anti-Yta.
    Davey RJ; Simpkins SS
    Transfusion; 1981; 21(6):702-5. PubMed ID: 7314218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. At(a-) phenotype: description of a family and reduced survival of At(a+) red cells in a proposita with anti-Ata.
    Sweeney JD; Holme S; McCall L; Huett D; Storry J; Reid M
    Transfusion; 1995 Jan; 35(1):63-7. PubMed ID: 7998074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A further example of the low frequency antigen Pta.
    Young DJ; Smith DS
    Clin Lab Haematol; 1983; 5(3):307-12. PubMed ID: 6653063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-i causing acute hemolysis following a negative immediate-spin crossmatch.
    Judd WJ; Steiner EA; Abruzzo LV; Davenport RD; Oberman HA; Pehta JC; Nance SJ
    Transfusion; 1992; 32(6):572-5. PubMed ID: 1502712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo red cell destruction by anti-Lu6.
    Issitt PD; Valinsky JE; Marsh WL; DiNapoli J; Gutgsell NS
    Transfusion; 1990; 30(3):258-60. PubMed ID: 2316000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro storage and in vivo survival studies of red cells from persons with the In(Lu) gene.
    Ballas SK; Marcolina MJ; Crawford MN
    Transfusion; 1992 Sep; 32(7):607-11. PubMed ID: 1519324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. INRA, a new high-frequency antigen in the INDIAN (IN023) blood group system.
    Joshi SR; Sheladiya A; Mendapara-Dobariya KV
    Asian J Transfus Sci; 2017; 11(2):121-123. PubMed ID: 28970678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term in vivo survival of Rh(D)-negative donor red cells in a patient with anti-LW.
    Chaplin H; Hunter VL; Rosche ME; Shirey RS
    Transfusion; 1985; 25(1):39-43. PubMed ID: 3918363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transfusion of multiple units of Js(b+) red blood cells in the presence of anti-Jsb in a patient with sickle beta-thalassemia disease and a review of the literature.
    Yuan S; Ewing NP; Bailey D; Salvador M; Wang S
    Immunohematology; 2007; 23(2):75-80. PubMed ID: 18004938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First example of hemolytic disease of the newborn caused by anti-Or and confirmation of the molecular basis of Or.
    Reid ME; Sausais L; Oyen R; Storry JR; Shukla H; Hsu T; Lim SM
    Vox Sang; 2000; 79(3):180-2. PubMed ID: 11111238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of pregnancy sensitized with anti-Inb with monocyte monolayer assay and maternal blood donation.
    Shree R; Ma KK; Er LS; Delaney M
    Immunohematology; 2018 Jan; 33(1):7-10. PubMed ID: 29608321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A clinically significant erythrocyte antibody detectable only by 51Cr survival studies.
    Baldwin ML; Barrasso C; Ness PM; Garratty G
    Transfusion; 1983; 23(1):40-4. PubMed ID: 6402832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship of Inb antigen to other antigens on In(Lu)-related p80.
    Telen MJ; Ferguson DJ
    Vox Sang; 1990; 58(2):118-21. PubMed ID: 1692655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of additional red cell alloantibodies after intrauterine transfusions.
    Viëtor HE; Kanhai HH; Brand A
    Transfusion; 1994; 34(11):970-4. PubMed ID: 7974705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.